These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24937157)

  • 1. Hemoconcentration-guided diuresis in heart failure.
    Vaduganathan M; Greene SJ; Fonarow GC; Voors AA; Butler J; Gheorghiade M
    Am J Med; 2014 Dec; 127(12):1154-9. PubMed ID: 24937157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoconcentration is a good prognostic predictor for clinical outcomes in acute heart failure: data from the Korean Heart Failure (KorHF) Registry.
    Oh J; Kang SM; Hong N; Youn JC; Han S; Jeon ES; Cho MC; Kim JJ; Yoo BS; Chae SC; Oh BH; Choi DJ; Lee MM; Ryu KH
    Int J Cardiol; 2013 Oct; 168(5):4739-43. PubMed ID: 23958420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
    Ter Maaten JM; Valente MA; Damman K; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Bloomfield DM; Cotter G; Davison B; Subacius H; van Veldhuisen DJ; van der Meer P; Hillege HL; Gheorghiade M; Voors AA
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27266853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of hemoconcentration during hospitalization for acute decompensated heart failure.
    Davila C; Reyentovich A; Katz SD
    J Card Fail; 2011 Dec; 17(12):1018-22. PubMed ID: 22123365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Titration of Neurohormonal Antagonists and Blood Pressure Reduction on Renal Function and Decongestion in Decompensated Heart Failure.
    Kula AJ; Hanberg JS; Wilson FP; Brisco MA; Bellumkonda L; Jacoby D; Coca SG; Parikh CR; Tang WHW; Testani JM
    Circ Heart Fail; 2016 Jan; 9(1):e002333. PubMed ID: 26699390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure.
    Griffin M; Rao VS; Fleming J; Raghavendra P; Turner J; Mahoney D; Wettersten N; Maisel A; Ivey-Miranda JB; Inker L; Tang WHW; Wilson FP; Testani JM
    Am J Cardiol; 2019 Dec; 124(11):1707-1711. PubMed ID: 31601358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance Between Hemoconcentration and Clinical Assessment of Decongestion in Acute Heart Failure.
    Darawsha W; Chirmicci S; Solomonica A; Wattad M; Kaplan M; Makhoul BF; Abassi ZA; Azzam ZS; Aronson D
    J Card Fail; 2016 Sep; 22(9):680-8. PubMed ID: 27079674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion.
    Testani JM; Brisco MA; Chen J; McCauley BD; Parikh CR; Tang WH
    J Am Coll Cardiol; 2013 Aug; 62(6):516-24. PubMed ID: 23747773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glucocorticoids in potentiating diuresis in heart failure patients with diuretic resistance.
    Liu C; Liu K
    J Card Fail; 2014 Sep; 20(9):625-9. PubMed ID: 24969700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival.
    Testani JM; Chen J; McCauley BD; Kimmel SE; Shannon RP
    Circulation; 2010 Jul; 122(3):265-72. PubMed ID: 20606118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of diuretics in acute decompensated heart failure].
    Akin I; Ince H; Rauchhaus M; Kische S; Rehders TC; Wenzel RR; Nienaber CA; Chatterjee T
    Praxis (Bern 1994); 2010 Jun; 99(12):705-14. PubMed ID: 20533230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
    García-Blas S; Bonanad C; Llàcer P; Ventura S; Núñez JM; Sánchez R; Chamorro C; Fácila L; de la Espriella R; Vaquer JM; Cordero A; Roqué M; Ortiz V; Racugno P; Bodí V; Valero E; Santas E; Moreno MDC; Miñana G; Carratalá A; Bondanza L; Payá A; Cardells I; Heredia R; Pellicer M; Valls G; Palau P; Bosch MJ; Raso R; Sánchez A; Bertomeu-González V; Bertomeu-Martínez V; Montagud-Balaguer V; Albiach-Montañana C; Pendás-Meneau J; Marcaida G; Cervantes-García S; San Antonio R; de Mingo E; Chorro FJ; Sanchis J; Núñez J;
    Rev Esp Cardiol (Engl Ed); 2017 Dec; 70(12):1067-1073. PubMed ID: 28341415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure.
    Aspromonte N; Cruz DN; Valle R; Bonello M; Tubaro M; Gambaro G; Marchese G; Santini M; Ronco C
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1049-63. PubMed ID: 21599566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.
    van der Meer P; Postmus D; Ponikowski P; Cleland JG; O'Connor CM; Cotter G; Metra M; Davison BA; Givertz MM; Mansoor GA; Teerlink JR; Massie BM; Hillege HL; Voors AA
    J Am Coll Cardiol; 2013 May; 61(19):1973-81. PubMed ID: 23500313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretic management in heart failure.
    Michael Felker G
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S68-72. PubMed ID: 20653715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate.
    Boyle A; Sobotka PA
    J Card Fail; 2006 May; 12(4):247-9. PubMed ID: 16679255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrolyte disturbances in patients with chronic heart failure--clinical, evolutive and therapeutic implications.
    Costache II; Cimpoeşu D; Petriş O; Petriş AO
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):708-13. PubMed ID: 23272514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical use of bumetanide].
    Pellerito R; Bertola D; Soragna A
    Clin Ter; 1981 Sep; 98(6):651-60. PubMed ID: 7285545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.